title: Central but not systemic inhibition of inducible nitric oxide synthase modulates oxytocin release during endotoxemic shock.
abstract: Previous studies have shown that immunological challenges as lipopolysaccharide (LPS) administration increases plasma oxytocin (OT) concentration. Nitric oxide (NO), a free radical gas directly related to the immune system has been implicated in the central modulation of neuroendocrine adaptive responses to immunological stress. This study aimed to test the hypothesis that the NO pathway participates in the control of OT release induced by LPS injection. For this purpose, adult male Wistar rats received bolus intravenous (i.v.) injection of LPS, preceded or not by i.v. or intracerebroventricular (i.c.v.) injections of aminoguanidine (AG), a selective inducible nitric oxide synthase (iNOS) inhibitor. Rats were decapitated after 2, 4 and 6h of treatment, for measurement of OT by radioimmunoassay. In a separate set of experiments, mean arterial pressure (MAP) and heart rate (HR) were measured every 15 min over 6h, using a polygraph. These studies revealed that LPS reduced MAP and increased HR at 4 and 6h post-injection. LPS significantly increased plasma OT concentration at 2 and 4h post-injection. Pre-treatment with i.c.v. AG further increased plasma OT concentration and attenuated the LPS-induced decrease in MAP, however, i.v. AG failed to show similar effects. Thus, iNOS pathway may activate a central inhibitory control mechanism that attenuates OT secretion during endotoxemic shock.
authors.affiliation: Department of General and Specialized Nursing, University of São Paulo, College of Nursing, Ribeirão Preto, São Paulo, Brazil.
authors.forename: Angelita Maria
authors.initials: AM
authors.lastname: Stabile
authors.forename: Viviana
authors.initials: V
authors.lastname: Moreto
authors.forename: José
authors.initials: J
authors.lastname: Antunes-Rodrigues
authors.forename: Evelin Capellari
authors.initials: EC
authors.lastname: Carnio
mesh_terms: D000818:Animals; D019446:Endotoxemia / Q000378:metabolism* / Q000503:physiopathology; D005260:Female; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors*; D010121:Oxytocin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D009569:Nitric Oxide; D010121:Oxytocin; D052247:Nitric Oxide Synthase Type II